NewLeaf Brands Acquires Colorado-Based Mydecine Group

April 6, 2020

NewLeaf Brands Inc. signed an LOI and subsequently a definitive agreement in April 2020 to acquire Mydecine Group, a Colorado-headquartered company focused on medicinal and infused mushroom cultivation, processing, product development and R&D. The deal contemplated the purchase of 100% of Mydecine for USD $850,000 payable in NewLeaf common shares; NewLeaf later operated the business as a wholly-owned subsidiary and rebranded to Mydecine Innovations Group.

Buyers
NewLeaf Brands Inc.
Targets
Mydecine Group
Industry
Biotechnology
Location
Colorado, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.